PD-L1 POSITIVE
Clinical trials for PD-L1 POSITIVE explained in plain language.
Never miss a new study
Get alerted when new PD-L1 POSITIVE trials appear
Sign up with your email to follow new studies for PD-L1 POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for hard-to-treat breast cancer: drug duo targets PD-L1 positive tumors
Disease control Not yet recruitingThis study tests a combination of two drugs, Sacituzumab Tirumotecan and Toripalimab, as a first treatment for people with a specific type of advanced triple-negative breast cancer that has a protein called PD-L1. The goal is to see if the combo shrinks tumors and how safe it is.…
Matched conditions: PD-L1 POSITIVE
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 26, 2026 10:16 UTC
-
New combo therapy targets tough breast cancer in phase 2 trial
Disease control Not yet recruitingThis study tests a two-drug combination (Sac-TMT and Tagitanlimab) in people with a specific type of advanced breast cancer called PD-L1-positive triple negative breast cancer that has been treated before. The goal is to see if the combination shrinks tumors or slows cancer growt…
Matched conditions: PD-L1 POSITIVE
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 26, 2026 08:20 UTC